MENU
+Compare
BAX
Stock ticker: NYSE
AS OF
Oct 24 closing price
Price
$23.02
Change
+$0.03 (+0.13%)
Capitalization
11.82B

BAX Baxter International Forecast, Technical & Fundamental Analysis

Baxter offers a variety of medical supplies and equipment to providers... Show more

BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BAX with price predictions
Oct 24, 2025

BAX's RSI Indicator recovers from oversold territory

The RSI Oscillator for BAX moved out of oversold territory on September 26, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 37 similar instances when the indicator left oversold territory. In of the 37 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 61 cases where BAX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 22, 2025. You may want to consider a long position or call options on BAX as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BAX just turned positive on October 14, 2025. Looking at past instances where BAX's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BAX advanced for three days, in of 290 cases, the price rose further within the following month. The odds of a continued upward trend are .

BAX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BAX entered a downward trend on October 06, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.615) is normal, around the industry mean (10.710). P/E Ratio (87.846) is within average values for comparable stocks, (53.501). Projected Growth (PEG Ratio) (1.997) is also within normal values, averaging (1.842). Dividend Yield (0.030) settles around the average of (0.016) among similar stocks. P/S Ratio (1.083) is also within normal values, averaging (12.578).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BAX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BAX is expected to report earnings to rise 1.34% to 59 cents per share on October 30

Baxter International BAX Stock Earnings Reports
Q3'25
Est.
$0.60
Q2'25
Missed
by $0.02
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.02
The last earnings report on July 31 showed earnings per share of 58 cents, missing the estimate of 61 cents. With 3.72M shares outstanding, the current market capitalization sits at 11.82B.
A.I.Advisor
published Dividends

BAX paid dividends on October 01, 2025

Baxter International BAX Stock Dividends
А dividend of $0.17 per share was paid with a record date of October 01, 2025, and an ex-dividend date of August 29, 2025. Read more...
A.I. Advisor
published General Information

General Information

a provider of a portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Baxter Parkway
Phone
+1 224 948-2000
Employees
60000
Web
https://www.baxter.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FLRG38.310.26
+0.69%
Fidelity U.S. Multifactor ETF
UPAR15.680.06
+0.37%
UPAR Ultra Risk Parity ETF
PJAN46.150.12
+0.26%
Innovator US Equity Power Buff ETF™ Jan
CPSM28.390.03
+0.11%
Calamos S&P 500 Str Alt Prt ETF-May
EQLT30.50N/A
N/A
iShares MSCI Emerging Mkts Qual Fac ETF

BAX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BAX has been closely correlated with ALGN. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAX jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
+0.13%
ALGN - BAX
72%
Closely correlated
-0.58%
LUNG - BAX
53%
Loosely correlated
+3.14%
STE - BAX
51%
Loosely correlated
-0.45%
SOLV - BAX
51%
Loosely correlated
-1.15%
SYK - BAX
51%
Loosely correlated
-0.33%
More

Groups containing BAX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
+0.13%
BAX
(2 stocks)
77%
Closely correlated
-0.23%
Pharmaceuticals
(380 stocks)
48%
Loosely correlated
+0.22%
Pharmaceuticals: Other
(103 stocks)
41%
Loosely correlated
-0.39%